Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Children's Oncology Group
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Hospital General de Mexico
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
First Affiliated Hospital of Zhejiang University
Children's Oncology Group
Children's Oncology Group
University of Nebraska
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Goethe University
Goethe University
M.D. Anderson Cancer Center
Virginia Commonwealth University
The First Affiliated Hospital of Soochow University
M.D. Anderson Cancer Center
Goethe University
Goethe University
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
PETHEMA Foundation
M.D. Anderson Cancer Center
Sun Yat-sen University
Case Comprehensive Cancer Center